Home UVB phototherapy in psoriasis: Effectiveness, Quality of life and Cost-effectiveness.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON20618

Enrollment

196

Registered

2004-12-27

Start date

2002-10-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Randomisation in two treatment groups: home UVB phototherapy or UVB phototherapy in the hospital (both therapies are common practice in the Netherlands).

Eligibility

Inclusion criteria

Inclusion criteria: 1. Psoriasis patients: plaque or guttata psoriasis; 2. Eligible for total-body home UVB phototherapy based on the severity of the psoriatic skin lesions; 3. Willing AND capable to participate in both possible treatment arms (treatment at home and in the hospital); 4. Sufficient knowledge of the dutch language; 5. Age 18 years or more; 6. Does have a telephone.

Exclusion criteria

Exclusion criteria: 1. Analphabetism; 2. Expected non-compliance; 3. History of malignicy of the skin; 4. Known UVB allergy; 5. Chronic Polymorfic Light Eruption (CPLE); 6. Use of (systemic) medication with known phototoxic or photo-allergic properties; 7. Use of the following systemic medication: Ciclosporin (neoral), Methotrexate, acitretin (neotigason); 8. History of ionising radiation.

Design outcomes

Primary

Measure	Time frame
PASI and SAPASI-scores.	—

Secondary

Measure	Time frame
Quality of Life (SF-36, EQ-5D, PDI) and Cost-effectiveness.	—

Contacts

Public ContactMayke B.G. Koek

University Medical Center Utrecht (UMCU), Department of Dermatology, HPN G02.12 P.O. Box 85500

M.B.G.Koek@azu.nl+31 (0)30 2507388

Outcome results